The Study of Polycystic Ovary Syndrome (PCOS) and Questionnaire

Polycystic Ovary Syndrome Clinical Trial

Official title:

The Study of Polycystic Ovary Syndrome (PCOS) and Questionnaire

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01256970
• Other study ID #: WFH-PCOS-99075
• Status: Completed
• Phase: N/A
• First received: December 7, 2010
• Last updated: September 10, 2013
• Start date: November 2010
• Est. completion date: January 2013

Study information

• Verified date: September 2013
• Source: Taipei Medical University WanFang Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Polycystic ovary syndrome (PCOS) is an extremely common disorder in women of reproductive age. Diagnosis of PCOS is principally based on clinical and physical findings. Diagnostic criteria and PCOS definitions used by clinicians and researchers are almost as heterogeneous as the syndrome. This first part of study is determine whether genetic polymorphisms influence hormonal and metabolic characteristics in Taiwanese patients with PCOS and controls. Furthermore, women with PCOS were reported with high risk of cardiovascular disease, the investigators planned to calculate the difference of carotid intima-media thickness (IMT) and B-type natriuretic peptide (BNP) between women with PCOS and normal control to determine the premature atherosclerosis of women with PCOS.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 306
• Est. completion date: January 2013
• Est. primary completion date: January 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 15 Years to 45 Years

Eligibility

Inclusion Criteria:

• women at reproductive age

• women with PCOS and women without PCOS

Exclusion Criteria:

• young women who had their menarche less than 3 years

• women older than 45 years old, Amenorrhea of menopause, hyperglycemia, hyperthyroidism, hypothyroidism, heart failure, lung failure, renal failure, anemia, dystrophy, gonitis

Related Conditions & MeSH terms

• Polycystic Ovary Syndrome
• Syndrome

Locations

Country	Name	City	State
Taiwan	Taipei Medical University-WanFang Hospital	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
Taipei Medical University WanFang Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Obesity is the predominant predictor of impaired glucose tolerance and metabolic disturbance in polycystic ovary syndrome.	To evaluate the contribution to glucose intolerance and metabolic syndrome of obesity combined with the diagnostic criteria of polycystic ovary syndrome (PCOS).	Prospectively study in University teaching hospital from 31 August 2010 to 31 August 2011.